LEADER 01343nam  22004695u 450 
001 9910155265203321
005 20211006144817.0
010   $a3-318-03193-3
035   $a(CKB)3780000000101257
035   $a(OCoLC)1046189947
035   $a(SZ-BaSKA)218515
035   $a(EXLCZ)993780000000101257
100   $a20211006d1974      uy             0
101 0 $aeng
135   $aurunu|||||
200 10$aChemotherapy under Special Conditions / $f editors, H. Schönfeld, R.W. Brockman, F.E. Hahn
210   $aBasel : $cS. Karger, $d1974
215   $a1 online resource (VIII + 210 pages) : $c  32 figures, 41 tables
311   $a3-8055-1646-0 
606   $aPharmacology
606   $aImmunology
606   $aInfectious Diseases
606   $aMetabolism
606   $aOncology
606   $aPharmaceutics
615 14$aPharmacology
615 14$aImmunology
615 14$aInfectious Diseases
615 14$aMetabolism
615 14$aOncology
615 14$aPharmaceutics
676   $a615/.58/08 s
676   $a615/.58
700   $aSchönfeld$b H$01215176
702  0$aBrockman$b Robert W.$f1924-
702  0$aHahn$b F. E$g(Fred Ernest),$f1916-
801  0$bUKSKG
801  1$bUKSKG
906   $aBOOK
912   $a9910155265203321
996   $aChemotherapy under Special Conditions$92813394
997   $aUNINA